The University of Cambridge says it successfully tested a vaccine with an AI-designed antigen https://www.engadget.com/2188241/university-of-cambridge-successfu
Researchers at the University of Cambridge have successfully tested a vaccine featuring an AI-designed antigen in human trials. This novel approach utilized machine learning to create a "super-antigen" capable of providing long-term protection against a broad range of coronaviruses, including those that could cause future pandemics. The trial, involving 39 healthy volunteers, reported no significant side effects and demonstrated a protective immune response against known and potential future viral threats. AI
IMPACT This AI-driven vaccine design could shift infectious disease prevention from reactive to proactive, offering broad protection against existing and future viral threats.